Treatment of Multidrug‐Resistant Tuberculosis in San Francisco: An Outpatient‐Based Approach

Abstract

Treatment of multidrug-resistant tuberculosis in HIV-seronegative patients largely on an outpatient basis was feasible and was associated with high cure rates and lower cost than in other published studies. Patients with underlying HIV infection had very poor outcomes.